Elanco Animal Health Incorporated Common Stock
Market Cap
12B
Short interest (May 15)
6.4%
Net Short (Jun 03 ): 0.1%
Borrow Fee
0.41%
↑ 54.5%
Available Shares
1M
↓ 26.8%
Price Chart
Company Overview
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.